Markets:

Overview

News

Currencies

International

Treasuries

Ginkgo Bioworks Holdings, Inc. Class A Common Stock (NY:DNA)

6.940 +0.190 (+2.81%)

Streaming Delayed Price Updated: 11:37 AM EDT, Sep 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Ginkgo Bioworks Holdings, Inc. Class A Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

After-Hours Action: Why Ginkgo Bioworks Stock Is Sliding ↗

May 10, 2023

Shares of cell programming platform company Ginkgo Bioworks Holdings Inc (NYSE: DNA) are moving lower after hours on the heels of a wider-than-expected quarterly loss.&nbs

Via Benzinga

DNA Stock Earnings: Ginkgo Bioworks Misses EPS, Beats Revenue Estimates ↗

May 10, 2023

DNA stock earnings show Ginkgo Bioworks missing analyst estimates for its loss per share but beating revenue estimates.

Via InvestorPlace

Ginkgo Bioworks Holdings: Q1 Earnings Insights ↗

May 10, 2023

Via Benzinga

Earnings Preview: Ginkgo Bioworks Holdings ↗

May 09, 2023

Via Benzinga

Down 76% From Its High, Can Ginkgo Bioworks Stock Turn Things Around? ↗

May 04, 2023

Ginkgo is coming off a strong performance in 2022, but this year will no doubt be a more challenging one for the business.

Via The Motley Fool

7 Best Cathie Wood Stocks for Your May 2023 Buy List ↗

May 02, 2023

This year promises to be very different for Cathie Wood stocks, as signs of economic improvement become more prominent.

Via InvestorPlace

Despite Its Falling 92%, Cathie Wood Is Buying More of This Growth Stock ↗

May 01, 2023

Wood is betting that Ginkgo Bioworks' biofoundry can scale up enough to become profitable.

Via The Motley Fool

Earnings Scheduled For March 1, 2023 ↗

March 01, 2023

Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.

Via Benzinga

Ginkgo Bioworks Holdings's Earnings: A Preview ↗

February 28, 2023

Via Benzinga

Is It Too Early to Invest in Ginkgo Bioworks? ↗

February 22, 2023

Ginkgo is on track to easily beat its guidance for 2022. But what about its bottom line?

Via The Motley Fool

Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries ↗

April 27, 2023

Evogene employs an artificial intelligence platform for decoding plant phenotypes and microbial genomes. Consider its' research agenda, applications, and at-the-market products. The set-up may present...

Via Talk Markets

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

April 21, 2023

The growth-focused money manager is making moves.

Via The Motley Fool

Cathie Wood Bets Big On Roblox With $19.5M Purchase — Also Loads Up On This Biotech Stock ↗

April 17, 2023

Via Benzinga

5 Penny Stocks With Explosive 5X Potential ↗

April 17, 2023

Penny stocks are inherently risky, but investing in low-priced companies with wide "moats" can shift the odds in investors' favor.

Via InvestorPlace

3 Growth Stocks to Buy for 100% Returns ↗

April 11, 2023

These three growth stocks to buy could provide triple-digit percentage returns for investors in the near to mid term.

Via InvestorPlace

Cathie Wood Loads Up On Biotech Stocks — Continues To Raise Stake In Coinbase Global ↗

April 06, 2023

Via Benzinga

This Growth Stock Is Down 63% in 1 Year. Here's Why You Should Buy the Dip and Hold It for 5 Years ↗

March 29, 2023

The bear market hasn't been kind, but the future could be a lot better.

Via The Motley Fool

Luminar Technologies, EHang Holdings And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

March 22, 2023

U.S. stock futures traded slightly lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Evogene Offers An Excellent Risk/Reward Ratio ↗

March 21, 2023

We think the company’s main CPB computational engine has the potential to be an extraordinary value creation engine. Investors only need one of the company's subsidiaries to succeed, to de-risk their...

Via Talk Markets

7 Penny Stocks With Massive Growth Potential ↗

March 20, 2023

If you laugh at red ink, these tempting ideas just might be for you.

Via InvestorPlace

Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank ↗

March 11, 2023

The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the...

Via Benzinga

Buy the Dip: 2 Exceptional Growth Stocks to Grab Before the Next Bull Market ↗

March 05, 2023

Now's the time to load up on stocks that got dented in the bear market.

Via The Motley Fool

This Biotech Is Already Using AI, but Is the Growth Stock a Buy? ↗

February 24, 2023

Few biotechs can claim to be using AI in as central of a role as Ginkgo Bioworks.

Via The Motley Fool

2 Bruised Growth Stocks to Buy While They're Cheap ↗

February 21, 2023

Both are on the verge of fast growth, and they haven't had any major setbacks yet.

Via The Motley Fool

The Next Big Disruptors? 3 Biotech Stocks Making Headlines. ↗

February 17, 2023

Biotech stocks were hard-hit in 2022, but these disruptive names in the field of synthetic biology can be big winners in 2023.

Via InvestorPlace

3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street ↗

February 07, 2023

These stocks are risky. But they just might deliver huge gains if analysts are right.

Via The Motley Fool

3 Penny Stocks That Could Rise 500% in 2023 ↗

January 13, 2023

Tilt the odds in your favor in 2023 with some of these high-potential penny stocks. The risks are high, but so are the rewards.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Wednesday ↗

January 04, 2023

On Wednesday, 35 companies reached new 52-week lows.

Via Benzinga

What You Missed On Wall Street On Friday ↗

December 31, 2022

In the midst of markets falling, some companies had good news, while others took a hit from analysts and a merger is still on hold.

Via Talk Markets

Three Pharma Stocks to Sell Before They Die ↗

December 24, 2022

As we head into New Year 2023, these are just some of the top pharma stocks to sell at the start of January.

Via InvestorPlace

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.